Pharmaceuticals Market Reports

Global Antibacterial Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Drug Class (Beta-Lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, Phenicols, Others), By Route of Administration (Parenteral, Enteral, Oral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By Region (North America, Europe, Asia Pacific, CSA, and the Middle East & Africa), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

The global antibacterial drugs market will grow from USD 35.2 billion in 2021 to USD 41.5 billion in 2026 at a CAGR of 4.2%. Antibacterial drugs destroy or inhibit the growth of microorganisms and bacteria. Antibiotics are antibacterial medications that are commonly utilized in the prevention and treatment of infectious diseases. Read More »
August 16 : 2021

Global Charcoal-based Oral Care Market Size, Trends & Analysis - Forecasts to 2026 By Product (Toothpaste, Toothbrush, Powder, Mouthwashes/Rinses, Floss, Others [Strips, Tablets]), By Ingredient (Activated Charcoal, Fluoride-based, Flouride-free, Others [Hemp Oil, Coconut Oil, Tea Tree Oil, Others]), By Distribution Channel (Supermarket/Hypermarket, Retail Pharmacies, Online Retail Stores, Convenience Stores, Others), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The global charcoal-based oral care market is projected to grow at a CAGR value of 4.2% during the forecast period [2021 to 2026]. The escalating incidence of tooth decay, periodontal diseases, and other dental illnesses soaring oral hygiene consciousness, expanding dental healthcare spending, and a burgeoning rate of research and development to introduce novel and safe charcoal-based dental hygiene products are some of the aspects driving the expansion of this market. Read More »
August 3 : 2021

Global Medical Silicone Sheet Market Size, Trends & Analysis - Forecasts to 2026 By Application (Surgical Wounds, Scar Patch, Burn Treatment), By End-User (Hospital & clinic, Ambulatory Surgical Center, Homecare), By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

The rise in the number of accidents leading to chronic wounds and their lifelong psychological impact on the patients has instigated demand for sustainable wound care products. The medical silicone sheet is among the most promising product in the field of wound and scar management. Read More »
July 30 : 2021

Global Systemic Lupus Erythematosus Market Size, Trends & Analysis - Forecasts to 2026 By Drug Class (Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs, Immunosuppressants, Corticosteroids, Disease-Modifying Anti-Rheumatic Drugs, BLyS-specific Inhibitors or Monoclonal Antibodies, Anticoagulants, Biologics, Others), By Route of Administration (Oral, Intravenous, Subcutaneous), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The systemic lupus erythematosus market is estimated to be valued at USD 3.30 Billion in 2021 and is projected to reach USD 4.67 Billion by 2026 at a CAGR of 7.2%. The core drivers which contribute to the market expansion include the increasing prevalence of chronic diseases, the growing need for targeted treatment, soaring levels of inflammatory diseases, increasing therapeutic interventions, and the emergence of biologics. Read More »
July 21 : 2021

Global Rheumatoid Arthritis Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Product (Biologics, Non-Biologics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Synthetic Disease-Modifying Antirheumatic Drugs, Other), Sales Channel (Prescription, OTC), By Route of Administration (Oral, Parenteral), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global rheumatoid arthritis therapeutics market is estimated to be valued at USD 25.66 billion in 2021 and is projected to reach USD 32.44 billion by 2026 at a CAGR of 4.8%. The key drivers which contribute to the market expansion include the increasing prevalence of chronic diseases, growing joint deformities, soaring need for advanced treatment solutions, growing inflammatory diseases, increasing emergence of biologics, a growing proportion of individuals suffering from autoimmune disorders, mounting demand & desire for novel therapeutics, continually evolving medical facilities, growing geriatric population, increasing technological advancements, expanding government initiatives, rising legal governance alignment, and increasing research and development. Read More »
July 16 : 2021

Global Local Anesthesia Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application (Injectable, Surface Anesthetic), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global local anesthesia drugs market is estimated to be valued at USD 5.60 billion in 2021 and is projected to reach USD 6.75 billion by 2026 at a CAGR of 3.8%. The core drivers which contribute to the market expansion include the increasing volume of surgeries related to chronic diseases, cardiovascular, accidents, cancer, nervous disorders and even getting relief from post-surgery. Read More »
July 15 : 2021